Nunes Anne bought ANIK
March 15, 2024 · Form 4 insider transaction
Nunes Anne bought 10,912 shares of Anika Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,912
Price
$0.00
Total value
N/A
InsiderNunes Anne
Role—
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateMarch 15, 2024
Filing dateMarch 19, 2024
Shares owned after10,912
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025.